ChristianaCare Health Services

Newark, Delaware 19718-2200

4 studies enrolling now · 77 studies all time

What they study most

Acute Heart Failure, Acute Myeloid Leukemia, Acute T Cell Leukemia Lymphoma, Advanced Cancer, Advanced or Metastatic Solid Tumor, Aging, Alzheimer's Disease, Angina, Stable, Angina, Unstable, Anticoagulants, Aortic Aneurysm, Abdominal, Atherosclerosis

Studies at this site

• A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer — Recruiting now
• Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment — Recruiting now
• Left Ventricular Structural Predictors of Sudden Cardiac Death — Recruiting now
• Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors — Recruiting now
• A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC) — Running, not enrolling
• Continuation of the nuMoM2b Heart Health Study — Enrolling by invitation
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS — Running, not enrolling
• INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC — Running, not enrolling
• An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab — Completed
• 9-ING-41 in Patients With Advanced Cancers — Running, not enrolling
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• RESPONDER-HF Trial — Running, not enrolling
• Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial — Running, not enrolling
• First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC) — Running, not enrolling
• FlowTriever All-Comer Registry for Patient Safety and Hemodynamics — Completed
• Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer — Stopped early
• Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States — Completed
• A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma — Stopped early
• Regional Versus General Anesthesia for Promoting Independence After Hip Fracture — Completed
• Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma — Paused
• A Phase II Open Label Study of BMS-582664 in Locally Advanced or Metastatic Hepatocellular Cancer — Completed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial — Status unconfirmed
• Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer. — Stopped early
• Chronic Hypertension and Pregnancy (CHAP) Project — Completed
• Neuroform Atlas Stent System Study — Completed
• A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria — Completed
• Vopratelimab and a CTLA-4 Inhibitor in PD-1/PD-L1 Inhibitor Experienced Subjects With NSCLC or Urothelial Cancer — Completed
• Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO) — Stopped early
• Strategic Management to Optimize Response To Cardiac Resynchronization Therapy — Completed
• The National Standard for Normal Fetal Growth — Completed
• Post-Approval Trial of the Talent™ Abdominal Stent Graft to Treat Aortic Aneurysms — Completed
• Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer — Completed
• Vest Prevention of Early Sudden Death Trial and VEST Registry — Completed
• Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants — Completed
• Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy — Status unconfirmed
• SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy — Completed
• EverFlex Post Approval Study — Completed
• A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections — Completed
• Cancer Symptom Data From Multiple Treatment Centers — Completed
• Cognition in the Study of Tamoxifen and Raloxifene — Completed
• Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus — Stopped early
• Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections — Completed
• Plaque Inflammation and Dysfunctional HDL in AIM-HIGH — Completed
• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma — Completed
• The NICHD Fetal Growth Study: Twin Gestations — Completed
• Movement Enhancing Device for Children — Completed
• Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients — Completed
• Foley With Oxytocin Versus Foley no Oxytocin for Induction of Labor — Completed